The Community Guide

- gsearch

Search Results

Narrow Results:

2024 1
2022 3
2021 3
2020 11
2019 4
2018 2
2017 4
2015 2

Fact Sheet 1

1 - 20 of 30 Results

Refine Results

Refine Results:

A meta-analysis of the performance of the PimaTM CD4 for point of care testing

CITE Title : A meta-analysis of the performance of the PimaTM CD4 for point of care testing Personal Author(s) : Scott, Lesley E.;Campbell, Jennifer;Westerman, Larry;Kestens, Luc;Vojnov, Lara;Kohastsu, Luciana;Nkengasong, John;Peter, Trevor;Stevens, Wendy; Published Date : Jul 25 2015 Series : PEPFAR Source : BMC Med. 13. URL : https://stacks.cdc.gov/view/cdc/43343 Scott, Lesley E. et al. (2015). A meta-analysis of the performance of the PimaTM CD4 for point of care testing. 13 Scott, Lesley E. et al. "A meta-analysis of the performance of the PimaTM CD4 for point of care testing" 13 (2015) Scott, Lesley E. et al. "A meta-analysis of the performance of the PimaTM CD4 for point of care testing" vol. 13, 2015 Export RIS Citation Information.

:

Scott, Lesley E. ;

Campbell, Jennifer

Jul 25 2015 | PEPFAR

:

BackgroundThe Alere point-of-care (POC) Pima™ CD4 analyzer allows for decentralized testing and expansion to testing antiretroviral therapy (ART) el...
Guidance for SARS-CoV-2 point-of-care testing

CITE Title : Guidance for SARS-CoV-2 point-of-care testing Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Oct. 14, 2020 URL : https://stacks.cdc.gov/view/cdc/95312 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Guidance for SARS-CoV-2 point-of-care testing. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Guidance for SARS-CoV-2 point-of-care testing" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Guidance for SARS-CoV-2 point-of-care testing" , 2020 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Oct. 14, 2020

:

Updated Oct. 14, 2020Point-of-care (POC) tests, such as some rapid tests for diagnosing an infectious disease, provide results within minutes of the t...
COVID-19 point-of-care batch testing tips

CITE Title : COVID-19 point-of-care batch testing tips Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 12/10/2020 Pages in Document : 2 numbered pages URL : https://stacks.cdc.gov/view/cdc/98699 Centers for Disease Control and Prevention (U.S.) (2020). COVID-19 point-of-care batch testing tips. Centers for Disease Control and Prevention (U.S.) "COVID-19 point-of-care batch testing tips" (2020) Centers for Disease Control and Prevention (U.S.) "COVID-19 point-of-care batch testing tips" , 2020 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

12/10/2020

:

These are general batch testing tips for a variety of COVID-19 tests.Follow the manufacturer’s instructions for batch testing.Find additional testin...
Guidance for SARS-CoV-2 point-of-care testing

CITE Title : Guidance for SARS-CoV-2 point-of-care testing Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Dec. 10, 2020 URL : https://stacks.cdc.gov/view/cdc/98620 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Guidance for SARS-CoV-2 point-of-care testing. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Guidance for SARS-CoV-2 point-of-care testing" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Guidance for SARS-CoV-2 point-of-care testing" , 2020 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Dec. 10, 2020

:

Updated Dec. 10, 2020Revisions were made on December 10, 2020 to reflect the following:• New “Help with Performing Point-of-Care Tests” section ...
Availability of Safety-net Sexually Transmitted Disease Clinical Services in the U.S., 2018

CITE Title : Availability of Safety-net Sexually Transmitted Disease Clinical Services in the U.S., 2018 Personal Author(s) : Leichliter, Jami S.;O’Donnell, Kari;Kelley, Kat;Cuffe, Kendra M.;Weiss, Gretchen;Gift, Thomas L.; Published Date : 4 2020;4-2020; Source : Am J Prev Med. 58(4):555-561 URL : https://stacks.cdc.gov/view/cdc/126891 Leichliter, Jami S. et al. (2020). Availability of Safety-net Sexually Transmitted Disease Clinical Services in the U.S., 2018. 58(4). Leichliter, Jami S. et al. "Availability of Safety-net Sexually Transmitted Disease Clinical Services in the U.S., 2018" 58, no. 4 (2020) Leichliter, Jami S. et al. "Availability of Safety-net Sexually Transmitted Disease Clinical Services in the U.S., 2018" vol. 58, no. 4, 2020 Export RIS Citation Information.

:

Leichliter, Jami S. ;

O’Donnell, Kari

4 2020 | Am J Prev Med. 58(4):555-561

:

Introduction:Safety-net sexually transmitted disease services can prevent transmission of sexually transmitted disease. This study assesses the availa...
Evaluation of SAMBA II: a qualitative and semi-quantitative HIV point-of-care nucleic acid test

CITE Title : Evaluation of SAMBA II: a qualitative and semi-quantitative HIV point-of-care nucleic acid test Personal Author(s) : Violette, Lauren R;Cornelius-Hudson, Andy;Snidarich, Madison;Niemann, Lisa A;Assennato, Sonny Michael;Ritchie, Allyson;Goel, Neha;Chavez, Pollyanna R;Ethridge, Steven F;Katz, David A.;Lee, Helen;Delaney, Kevin P;Stekler, Joanne D; Published Date : 4 15 2022;4-15-; Source : J Acquir Immune Defic Syndr. 89(5):537-545 URL : https://stacks.cdc.gov/view/cdc/116939 Violette, Lauren R et al. (2022). Evaluation of SAMBA II: a qualitative and semi-quantitative HIV point-of-care nucleic acid test. 89(5). Violette, Lauren R et al. "Evaluation of SAMBA II: a qualitative and semi-quantitative HIV point-of-care nucleic acid test" 89, no. 5 (2022) Violette, Lauren R et al. "Evaluation of SAMBA II: a qualitative and semi-quantitative HIV point-of-care nucleic acid test" vol. 89, no. 5, 2022 Export RIS Citation Information.

:

Violette, Lauren R ;

Cornelius-Hudson, Andy

4 15 2022 | J Acquir Immune Defic Syndr. 89(5):537-545

:

Background:Point-of-care (POC) nucleic acid tests (NAT) have potential to diagnose acute HIV infection and monitor persons taking pre-exposure prophyl...
Guidance for SARS-CoV-2 rapid testing performed in point-of-care settings

CITE Title : Guidance for SARS-CoV-2 rapid testing performed in point-of-care settings Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Jan. 19, 2022 URL : https://stacks.cdc.gov/view/cdc/113538 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2022). Guidance for SARS-CoV-2 rapid testing performed in point-of-care settings. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Guidance for SARS-CoV-2 rapid testing performed in point-of-care settings" (2022) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Guidance for SARS-CoV-2 rapid testing performed in point-of-care settings" , 2022 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Jan. 19, 2022

:

Updated Jan. 19, 2022
Guidance for SARS-CoV-2 point-of-care testing

CITE Title : Guidance for SARS-CoV-2 point-of-care testing Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Feb. 5 2021 URL : https://stacks.cdc.gov/view/cdc/101985 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Guidance for SARS-CoV-2 point-of-care testing. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Guidance for SARS-CoV-2 point-of-care testing" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Guidance for SARS-CoV-2 point-of-care testing" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Feb. 5 2021

:

Updated Feb. 5, 2021Revisions were made on December 10, 2020 to reflect the following:• New “Help with Performing Point-of-Care Tests” section a...
Evaluation of Specimen Types for Pima CD4 Point-of-Care Testing: Advantages of Fingerstick Blood Collection into an EDTA Microtube

CITE Title : Evaluation of Specimen Types for Pima CD4 Point-of-Care Testing: Advantages of Fingerstick Blood Collection into an EDTA Microtube Personal Author(s) : Kohatsu, Luciana;Bolu, Omotayo;Schmitz, Mary E.;Chang, Karen;Lemwayi, Ruth;Arnett, Nichole;Mwasekaga, Michael;Nkengasong, John;Mosha, Fausta;Westerman, Larry E.; Published Date : Aug 23 2018 Source : PLoS One. 13(8). URL : https://stacks.cdc.gov/view/cdc/59278 Kohatsu, Luciana et al. (2018). Evaluation of Specimen Types for Pima CD4 Point-of-Care Testing: Advantages of Fingerstick Blood Collection into an EDTA Microtube. 13(8). Kohatsu, Luciana et al. "Evaluation of Specimen Types for Pima CD4 Point-of-Care Testing: Advantages of Fingerstick Blood Collection into an EDTA Microtube" 13, no. 8 (2018) Kohatsu, Luciana et al. "Evaluation of Specimen Types for Pima CD4 Point-of-Care Testing: Advantages of Fingerstick Blood Collection into an EDTA Microtube" vol. 13, no. 8, 2018 Export RIS Citation Information.

:

Kohatsu, Luciana ;

Bolu, Omotayo

Aug 23 2018 | PLoS One. 13(8).

:

IntroductionEffective point-of-care testing (POCT) is reliant on optimal specimen collection, quality assured testing, and expedited return of results...
Feasibility of a point-of-care test based on quantum dots with a mobile phone reader for detection of antibody responses

CITE Title : Feasibility of a point-of-care test based on quantum dots with a mobile phone reader for detection of antibody responses Personal Author(s) : Lee, Chan;Noh, John;O’Neal, Seth E.;Gonzalez, Armando E.;Garcia, Hector H.;Handali, Sukwan; Corporate Authors(s) : Cysticercosis Working Group in Peru Published Date : October 07 2019 Source : PLoS Negl Trop Dis. 13(10) URL : https://stacks.cdc.gov/view/cdc/89000 Lee, Chan et al. (2019). Feasibility of a point-of-care test based on quantum dots with a mobile phone reader for detection of antibody responses. 13(10). Lee, Chan et al. "Feasibility of a point-of-care test based on quantum dots with a mobile phone reader for detection of antibody responses" 13, no. 10 (2019) Lee, Chan et al. "Feasibility of a point-of-care test based on quantum dots with a mobile phone reader for detection of antibody responses" vol. 13, no. 10, 2019 Export RIS Citation Information.

:

Lee, Chan ;

Noh, John

October 07 2019 | PLoS Negl Trop Dis. 13(10)

:

We developed a novel and portable fluorescent sensor that integrates a lateral flow assay with a quantum dot (Qdots) label and a mobile phone reader f...
Use, Safety Assessment, and Implementation of Two Point-of-Care Tests for COVID-19 Testing

CITE Title : Use, Safety Assessment, and Implementation of Two Point-of-Care Tests for COVID-19 Testing Personal Author(s) : Hahn, Megan;Olsen, Aaron;Stokes, Kindra;Fowler, Randal C;Gu, Rui;Semple-Lytch, Shellanne;DeVito, Andrea;Kurpiel, Philip;Hughes, Scott;Rakeman, Jennifer L; Published Date : 7 24 2021 Source : Am J Clin Pathol. 2021; URL : https://stacks.cdc.gov/view/cdc/121634 Hahn, Megan et al. (2021). Use, Safety Assessment, and Implementation of Two Point-of-Care Tests for COVID-19 Testing. Hahn, Megan et al. "Use, Safety Assessment, and Implementation of Two Point-of-Care Tests for COVID-19 Testing" (2021) Hahn, Megan et al. "Use, Safety Assessment, and Implementation of Two Point-of-Care Tests for COVID-19 Testing" , 2021 Export RIS Citation Information.

:

Hahn, Megan ;

Olsen, Aaron

7 24 2021 | Am J Clin Pathol. 2021;

:

ObjectivesThe Abbot ID NOW COVID-19 assay and Quidel Sofia 2 SARS Antigen FIA are point-of-care assays that offer rapid testing for severe acute respi...
Successful Use of Near Point-of-Care Early Infant Diagnosis in NAMPHIA to Improve Turnaround Times in a National Household Survey

CITE Title : Successful Use of Near Point-of-Care Early Infant Diagnosis in NAMPHIA to Improve Turnaround Times in a National Household Survey Personal Author(s) : Domaoal, Robert A.;Sleeman, Katrina;Sawadogo, Souleymane;Dzinamarira, Tafadzwa;Frans, Ndahafa;Shatumbu, Saara P.;Kakoma, Ligamena N.;Shuumbwa, Terthu K.;Cox, Mackenzie Hurlston;Stephens, Sally;Nisbet, Lydia;Metz, Melissa;Saito, Suzue;Williams, Daniel B.;Voetsch, Andrew C.;Patel, Hetal;Parekh, Bharat;Duong, Yen T.; Published Date : 8 01 2021 Source : J Acquir Immune Defic Syndr. 87(Suppl 1):S67-S72 URL : https://stacks.cdc.gov/view/cdc/113363 Domaoal, Robert A. et al. (2021). Successful Use of Near Point-of-Care Early Infant Diagnosis in NAMPHIA to Improve Turnaround Times in a National Household Survey. 87 Domaoal, Robert A. et al. "Successful Use of Near Point-of-Care Early Infant Diagnosis in NAMPHIA to Improve Turnaround Times in a National Household Survey" 87 (2021) Domaoal, Robert A. et al. "Successful Use of Near Point-of-Care Early Infant Diagnosis in NAMPHIA to Improve Turnaround Times in a National Household Survey" vol. 87, 2021 Export RIS Citation Information.

:

Domaoal, Robert A. ;

Sleeman, Katrina

8 01 2021 | J Acquir Immune Defic Syndr. 87(Suppl 1):S67-S72

:

Background:In the Population-based HIV Impact Assessment (PHIA) surveys, early infant diagnosis (EID) was provided to infants <18 months without a pri...
Potential for Point-of-Care Tests to Reduce Chlamydia-associated Burden in the United States: A Mathematical Modeling Analysis

CITE Title : Potential for Point-of-Care Tests to Reduce Chlamydia-associated Burden in the United States: A Mathematical Modeling Analysis Personal Author(s) : Rönn, Minttu M.;Menzies, Nicolas A.;Gift, Thomas L.;Chesson, Harrell W.;Trikalinos, Tom A.;Bellerose, Meghan;Malyuta, Yelena;Berruti, Andrés;Gaydos, Charlotte A.;Hsu, Katherine K.;Salomon, Joshua A.; Published Date : April 15 2020 Source : Clin Infect Dis. 70(9):1816-1823 URL : https://stacks.cdc.gov/view/cdc/85479 Rönn, Minttu M. et al. (2020). Potential for Point-of-Care Tests to Reduce Chlamydia-associated Burden in the United States: A Mathematical Modeling Analysis. 70(9). Rönn, Minttu M. et al. "Potential for Point-of-Care Tests to Reduce Chlamydia-associated Burden in the United States: A Mathematical Modeling Analysis" 70, no. 9 (2020) Rönn, Minttu M. et al. "Potential for Point-of-Care Tests to Reduce Chlamydia-associated Burden in the United States: A Mathematical Modeling Analysis" vol. 70, no. 9, 2020 Export RIS Citation Information.

:

Rönn, Minttu M. ;

Menzies, Nicolas A.

April 15 2020 | Clin Infect Dis. 70(9):1816-1823

:

Background.Point-of-care testing (POCT) assays for chlamydia are being developed. Their potential impact on the burden of chlamydial infection in the ...
Hepatitis C Management at Federally Qualified Health Centers during the Opioid Epidemic: A Cost-Effectiveness Study

CITE Title : Hepatitis C Management at Federally Qualified Health Centers during the Opioid Epidemic: A Cost-Effectiveness Study Personal Author(s) : ASSOUMOU, Sabrina A.;NOLEN, Shayla;HAGAN, Liesl;WANG, Jianing;EFTEKHARI YAZDI, Golnaz;THOMPSON, William W.;MAYER, Kenneth H.;PURO, Jon;ZHU, Lin;SALOMON, Joshua A.;LINAS, Benjamin P.; Published Date : 11 2020 Source : Am J Med. 133(11):e641-e658 URL : https://stacks.cdc.gov/view/cdc/105264 ASSOUMOU, Sabrina A. et al. (2020). Hepatitis C Management at Federally Qualified Health Centers during the Opioid Epidemic: A Cost-Effectiveness Study. 133(11). ASSOUMOU, Sabrina A. et al. "Hepatitis C Management at Federally Qualified Health Centers during the Opioid Epidemic: A Cost-Effectiveness Study" 133, no. 11 (2020) ASSOUMOU, Sabrina A. et al. "Hepatitis C Management at Federally Qualified Health Centers during the Opioid Epidemic: A Cost-Effectiveness Study" vol. 133, no. 11, 2020 Export RIS Citation Information.

:

ASSOUMOU, Sabrina A. ;

NOLEN, Shayla

11 2020 | Am J Med. 133(11):e641-e658

:

Background:The opioid epidemic has been associated with an increase in hepatitis C virus (HCV) infections. Federally qualified health centers (FQHCs) ...
Guidance for SARS-CoV-2 point-of-care testing

CITE Title : Guidance for SARS-CoV-2 point-of-care testing Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Nov. 24, 2020 URL : https://stacks.cdc.gov/view/cdc/97772 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Guidance for SARS-CoV-2 point-of-care testing. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Guidance for SARS-CoV-2 point-of-care testing" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Guidance for SARS-CoV-2 point-of-care testing" , 2020 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Nov. 24, 2020

:

Updated Nov. 24, 2020Revisions were made on  November 13,  2020 to include:  Added Frequently Asked Questions about Point-of-Care Testing.Point-...
Guidance for SARS-CoV-2 point-of-care testing

CITE Title : Guidance for SARS-CoV-2 point-of-care testing Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Nov. 13, 2020 URL : https://stacks.cdc.gov/view/cdc/97201 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Guidance for SARS-CoV-2 point-of-care testing. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Guidance for SARS-CoV-2 point-of-care testing" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Guidance for SARS-CoV-2 point-of-care testing" , 2020 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Nov. 13, 2020

:

Updated Nov. 13, 2020Point-of-care (POC) tests, such as some rapid tests for diagnosing an infectious disease, provide results within minutes of the t...
Guidance for SARS-CoV-2 rapid testing performed in point-of-care settings

CITE Title : Guidance for SARS-CoV-2 rapid testing performed in point-of-care settings Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Apr. 4, 2022 URL : https://stacks.cdc.gov/view/cdc/115981 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2022). Guidance for SARS-CoV-2 rapid testing performed in point-of-care settings. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Guidance for SARS-CoV-2 rapid testing performed in point-of-care settings" (2022) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Guidance for SARS-CoV-2 rapid testing performed in point-of-care settings" , 2022 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Apr. 4, 2022

:

Updated Apr. 4, 2022
A New Tool to Diagnose Tuberculosis : The Xpert MTB/RIF Assay

CITE Title : A New Tool to Diagnose Tuberculosis : The Xpert MTB/RIF Assay Corporate Authors(s) : National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination. Published Date : 04/05/2015 Pages in Document : 2 unnumbered pages URL : https://stacks.cdc.gov/view/cdc/132190 National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination. (2015). A New Tool to Diagnose Tuberculosis : The Xpert MTB/RIF Assay. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination. "A New Tool to Diagnose Tuberculosis : The Xpert MTB/RIF Assay" (2015) National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination. "A New Tool to Diagnose Tuberculosis : The Xpert MTB/RIF Assay" , 2015 Export RIS Citation Information.

:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.

04/05/2015

:

The Xpert MTB/RIF assay is a new test that is revolutionizing tuberculosis (TB) control by contributing to the rapid diagnosis of TB disease and drug ...
Symptom- and Laboratory-Based Ebola Risk Scores to Differentiate Likely Ebola Infections

CITE Title : Symptom- and Laboratory-Based Ebola Risk Scores to Differentiate Likely Ebola Infections Personal Author(s) : Oza, Shefali;Sesay, Alieu A.;Russell, Neal J.;Wing, Kevin;Boufkhed, Sabah;Vandi, Lahai;Sebba, Sahr C.;Cummings, Rachael;Checchi, Francesco; Published Date : Nov 2017 Source : Emerg Infect Dis. 23(11):1792-1799. URL : https://stacks.cdc.gov/view/cdc/49572 Oza, Shefali et al. (2017). Symptom- and Laboratory-Based Ebola Risk Scores to Differentiate Likely Ebola Infections. 23(11). Oza, Shefali et al. "Symptom- and Laboratory-Based Ebola Risk Scores to Differentiate Likely Ebola Infections" 23, no. 11 (2017) Oza, Shefali et al. "Symptom- and Laboratory-Based Ebola Risk Scores to Differentiate Likely Ebola Infections" vol. 23, no. 11, 2017 Export RIS Citation Information.

:

Oza, Shefali ;

Sesay, Alieu A.

Nov 2017 | Emerg Infect Dis. 23(11):1792-1799.

:

Rapidly identifying likely Ebola patients is difficult because of a broad case definition, overlap of symptoms with common illnesses, and lack of rapi...
Assessment of the utility of a symptom-based algorithm for identifying febrile patients for malaria diagnostic testing in Senegal

CITE Title : Assessment of the utility of a symptom-based algorithm for identifying febrile patients for malaria diagnostic testing in Senegal Personal Author(s) : Thwing, Julie;Ba, Fatou;Diaby, Alou;Diedhiou, Younouss;Sylla, Assane;Sall, Guelaye;Diouf, Mame Birame;Gueye, Alioune Badara;Gaye, Seynabou;Ndiop, Medoune;Cisse, Moustapha;Ndiaye, Daouda;Ba, Mady; Published Date : Mar 01 2017 Source : Malar J. 16. URL : https://stacks.cdc.gov/view/cdc/44560 Thwing, Julie et al. (2017). Assessment of the utility of a symptom-based algorithm for identifying febrile patients for malaria diagnostic testing in Senegal. 16 Thwing, Julie et al. "Assessment of the utility of a symptom-based algorithm for identifying febrile patients for malaria diagnostic testing in Senegal" 16 (2017) Thwing, Julie et al. "Assessment of the utility of a symptom-based algorithm for identifying febrile patients for malaria diagnostic testing in Senegal" vol. 16, 2017 Export RIS Citation Information.

:

Thwing, Julie ;

Ba, Fatou

Mar 01 2017 | Malar J. 16.

:

BackgroundMalaria rapid diagnostic tests (RDTs) enable point-of-care testing to be nearly as sensitive and specific as reference microscopy. The Seneg...

1 - 20 / 30